Should testosterone be added to estrogen-progestin therapy for breast protection?

被引:3
|
作者
Burger, Henry G. [1 ]
机构
[1] Prince Henrys Inst, Jean Hailes Fdn Womens Hlth, Clayton, Vic, Australia
关键词
D O I
10.1097/GME.0b013e31802cdddd
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
引用
收藏
页码:159 / 162
页数:4
相关论文
共 50 条
  • [1] Risk of breast cancer with estrogen-progestin replacement therapy
    OBSTETRICS AND GYNECOLOGY, 2001, 98 (06): : 1181 - 1183
  • [3] Hyperandrogenism and estrogen-progestin therapy
    Lello, S.
    GIORNALE ITALIANO DI OSTETRICIA E GINECOLOGIA, 2009, 31 (1-2): : 79 - 80
  • [4] Estrogen and estrogen-progestin replacement therapy and breast cancer risk.
    Schairer, C
    Lubin, J
    Troisi, R
    Sturgeon, S
    Brinton, L
    Hoover, R
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 1999, 149 (11) : S57 - S57
  • [5] Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk
    Schairer, C
    Lubin, J
    Troisi, R
    Sturgeon, S
    Brinton, L
    Hoover, R
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (04): : 485 - 491
  • [6] Postmenopausal estrogen-progestin therapy in relation to cancers of the endometrium and breast
    Weiss, NS
    Beresford, SAA
    Stanford, JL
    Voigt, LF
    HORMONAL CARCINOGENESIS II, 1996, : 287 - 294
  • [7] Breast cancer incidence in women exposed to estrogen and estrogen-progestin replacement therapy
    Persson, I
    HORMONAL CARCINOGENESIS II, 1996, : 91 - 98
  • [8] Estrogen and estrogen-progestin replacement therapy and risk of postmenopausal breast cancer in Canada
    Kirsh, V
    Kreiger, N
    CANCER CAUSES & CONTROL, 2002, 13 (06) : 583 - 590
  • [9] SPIRONOLACTONE AND ESTROGEN-PROGESTIN THERAPY FOR HIRSUTISM
    BOARD, JA
    ROSENBERG, SM
    SMELTZER, JS
    SOUTHERN MEDICAL JOURNAL, 1987, 80 (04) : 483 - 486
  • [10] Estrogen-progestin replacement therapy and atherosclerosis
    Punnonen, R
    JOkela, H
    Dastidar, P
    Aine, R
    Laippala, P
    MATURITAS, 1996, 23 : S61 - S64